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Herpesvirus DNA is packaged into capsids in the nuclei of infected cells in a process requiring at least six
viral proteins. Of the proteins required for encapsidation of viral DNA, UL15 and UL28 are the most conserved
among herpes simplex virus type 1 (HSV), varicella-zoster virus, and equine herpesvirus 1. The subcellular
distribution of the pseudorabies virus (PRV) UL28 protein was examined by in situ immunofluorescence. UL28
was present in the nuclei of infected cells; however, UL28 was limited to the cytoplasm in the absence of other
viral proteins. When cells expressing variant forms of UL28 were infected with a PRV UL28-null mutant, UL28
entered the nucleus, provided the carboxyl-terminal 155 amino acids were present. Additionally, PRV UL28
entered the nucleus in cells infected with HSV. Two HSV packaging proteins were tested for the ability to affect
the subcellular distribution of UL28. Coexpression of HSV UL15 enabled PRV UL28 to enter the nucleus in a
manner that required the carboxyl-terminal 155 amino acids of UL28. Coexpression of HSV UL25 did not affect
the distribution of UL28. We propose that an interaction between UL15 and UL28 facilitates the transport of
a UL15-UL28 complex to the infected-cell nucleus.
Herpesvirus DNA is packaged into preassembled capsids in
the nuclei of infected cells in a process that is not clearly
understood. At least six genes that are required for the encap-
sidation of concatemeric viral DNA into preassembled nucleo-
capsids have been identified in herpes simplex virus type 1
(HSV) (2, 4, 6, 11, 18, 21–23, 26). Viruses with deletions or
temperature-sensitive mutations in these genes possess similar
phenotypes. Under nonpermissive conditions the mutants fail
to cleave monomer-length genomes from the concatemeric
form, resulting in the accumulation of concatemeric virus ge-
nomes and capsids lacking DNA.
Pseudorabies virus (PRV) is an alphaherpesvirus closely re-
lated to HSV and serves as a valuable tool for the study of
herpesvirus DNA encapsidation. The UL28-null encapsidation
mutant PRV(332-31) is characterized by the same phenotype
as the UL28-null HSV gCB mutant (14, 23). In several cases,
PRV and HSV proteins can functionally substitute for their
homologs (15, 16).
Efforts to better characterize and understand the properties
of the six proteins required for encapsidation have recently
been made. PRV UL28 had been visualized within the nuclei
of infected cells (19), and it was presumed that UL28 con-
tained a nuclear localization signal (NLS) similar to that re-
ported for the simian virus 40 (SV40) T antigen (9). In this
work, experiments were performed to demonstrate that UL28
does not possess a classical NLS, that UL28 requires another
viral protein in order to enter the nucleus, and that the HSV
UL15 protein can fulfill that requirement.
MATERIALS AND METHODS
Cells and viruses. African green monkey kidney cells (Vero; ATCC CRL-
1586) were propagated in Dulbecco’s modified Eagle’s medium supplemented
with 5% fetal calf serum (HyClone) plus 50 U of penicillin G per ml and 50 mg
of streptomycin sulfate (Life Technologies) per ml. PRV(Becker) and HSV-
(KOS) were used as the wild-type strains.
A cell line transformed with the PRV UL28 and gB genes was constructed as
follows. Vero cells were cotransfected with pECP108 plus pSV2neo and selected
for resistance to 500 mg of G418 (Life Technologies) per ml. Colonies were
screened for functional PRV UL28 and PRV gB activities by their ability to
support plaque formation of the HSV gB-null mutant HSV(KDT) (5) and the
PRV UL28-null mutant PRV(332-31) (14). A cell line that expressed both UL28
and gB upon infection was named V108. The ability of PRV gB to complement
an HSV gB-null mutant was previously demonstrated (15). V108 cells were
maintained in media containing 100 mg of G418/ml.
Antisera. Polyclonal rabbit antisera were raised against purified fusion pro-
teins expressed in Escherichia coli. PRV UL28 was expressed as a Cro-UL28
fusion to produce D71 antiserum (19). HSV UL15 was expressed as a maltose-
binding protein-UL15 (exon 2) fusion to generate AS9 antiserum (27), and HSV
UL25 was expressed as a glutathione S-transferase-UL25 fusion to generate ID1
antiserum.
Plasmids. PRV UL28 was cloned into the expression vector pLuxF3 (24) as
pECP93 to express UL28 under the control of the SV40 promoter. A series of
UL28 deletion mutations was derived from pECP93. UL28D1 contained a dele-
tion between the StuI and MscI sites to eliminate codons 93 through 218.
UL28D2 contained a deletion between the MscI and SphI sites to eliminate
codons 219 through 393. UL28D3 contained a deletion between the SphI and
HincII sites to eliminate codons 393 through 569. UL28D4 contained a deletion
between the HincII and NheI sites to eliminate codons 570 through 724. UL28D2,
UL28D3, and UL28D4 had EcoRI oligonucleotide linkers inserted to maintain
the reading frame. An NLS from the SV40 T antigen was inserted between
codons 37 and 38 of UL28 by ligating the oligonucleotide 59 CGC GTA TGG
CCA AAA AAG AAG AGA AAG GTC 39 and its complement with appropriate
ends into the MluI site to generate UL28/NLS.
HSV proteins were expressed under the control of the cytomegalovirus major
immediate-early promoter in plasmid pF19-CMV (8). HSV UL15 cDNA was
constructed by insertion of the exon 1 and exon 2 splice junction into the genomic
DNA (27). HSV UL25 was from a genomic clone (pKEF-B5 [7]).
Plasmid pECP108, containing the PRV UL28 and gB genes, was used to
construct the recombinant cell line V108. pECP108 contained a NotI-NcoI frag-
ment spanning UL28 and gB.
Transfection and immunofluorescence. Vero cells were plated at 10 to 20%
confluence on coverslips and transfected with plasmid DNAs. Plasmid DNAs in
serum-free media (Opti-MEM I; Life Technologies) were mixed with a cationic
lipid (pFx-3; Invitrogen) in serum-free medium and added to the cell monolayer
for 24 h. The medium was replaced with Dulbecco’s modified Eagle’s medium
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plus fetal calf serum and antibiotics and incubated at 37°C for an additional 24 h.
Cells were fixed with formaldehyde and permeabilized with Nonidet P-40 as
previously described (19). The primary antisera (1:250 dilution) in phosphate-
buffered saline (PBS) plus 5% nonfat dry milk were incubated with the cells for
more than 90 min. The cells were rinsed in PBS and incubated with a secondary,
tetramethyl rhodamine isothiocyanate-conjugated goat anti-rabbit immunoglob-
ulin G antiserum (1:50 dilution; Sigma) for more than 90 min. The coverslips
were rinsed in PBS and mounted onto slides. Cells were observed by epifluores-
cence on a Zeiss Axioplan microscope with a 100-W UV lamp and photo-
graphed.
RESULTS
Subcellular distribution of PRV UL28. PRV UL28 has been
shown to accumulate in the nuclei of infected cells (19). A
series of experiments was performed to identify sequences
required for localization of UL28 to the nucleus. Vero cells
were infected with PRV(Be) and examined by in situ indirect
immunofluorescence for the distribution of UL28 (Fig. 1A).
UL28 was distributed throughout the cell but was most prom-
inent in the nucleus. When a plasmid encoding PRV UL28 was
transfected into Vero cells and the cells were examined by
immunofluorescence, UL28 was limited to the cytoplasm (Fig.
1B). This demonstrated that UL28 did not possess a distinct
functional NLS and suggested that an interaction with one or
more other virus-induced proteins was responsible for the nu-
clear localization during infection. Previous evidence sug-
gested that UL28 associated with another protein during in-
fection (19). To demonstrate that UL28 was not actively
retained in the cytoplasm, a decacodon NLS derived from the
SV40 T antigen (9) was inserted within UL28 (Fig. 2). UL28/
NLS was expressed in Vero cells and found within the nucleus
(Fig. 1C). The UL28/NLS protein was not absent from the
cytoplasm but had acquired the ability to enter the nucleus.
The immunofluorescent signals in the photographs are sig-
nificantly above the background level in this and subsequent
experiments. Every cell is adjacent to cells that do not express
UL28. These nonexpressing cells represent the background
level and are too weak to be detected under the conditions that
permit the visualization by immunofluorescence of the express-
ing cells. The possibility that the transient-expression plasmid
pECP93 had acquired one or more mutations that may have
caused the restriction to the cytoplasm was addressed. A stable
pECP93-transformed cell line that permitted plaque formation
by PRV(332-31) was isolated, indicating that pECP93 encodes
and expresses functional UL28 (20).
Identification of the sequences within UL28 required for
nuclear localization. Full-length UL28 did not possess a func-
tional NLS and was likely to require another virus-induced
protein for transport to the nucleus. A series of experiments
were conducted to identify the domain within UL28 likely to be
necessary to signal its transport to the nucleus. A series of
deletion mutations which spanned UL28 was made (Fig. 2).
The UL28 deletion plasmids were transfected singly into Vero
cells, and the distribution of UL28 within these cells was ex-
amined by immunofluorescence (Fig. 3). All of the proteins
were detected at significant levels in transfected cells, suggest-
ing that they retained epitopes for detection by the D71 poly-
clonal antiserum and were stable under the conditions used.
Protein stability was addressed by examining the strength of
immunofluorescence signals at 24 and 48 h posttransfection.
The signals were of greater intensity at 48 h than at 24 h,
suggesting that the protein levels accumulated with time. Al-
though the signal intensities increased with time, the individual
UL28 variant proteins exhibited different distribution patterns.
The UL28, UL28D1, UL28D3, and UL28D4 proteins exhibited
signals limited to the cytoplasm (Fig. 3A, B, D, and E). How-
ever, the UL28D2 protein was evenly distributed throughout
the cell (Fig. 3C). The means by which UL28D2 entered the
nucleus is not understood. The amino acids joined as a result
of the deletion did not fit consensus nuclear localization do-
main patterns. It is also unlikely that the protein’s smaller size
was responsible for its ability to enter the nucleus, since all of
the shortened proteins were of comparable sizes. Another pos-
sibility is presented in the Discussion.
FIG. 1. In situ detection of PRV UL28. (A) Vero cells grown on coverslips
were infected with PRV at an MOI of 0.1 and harvested 6 h postinfection for
immunofluorescence. (B and C) Vero cells were grown on coverslips and trans-
fected with plasmids to express either UL28 (B) or UL28/NLS (C). The proteins
were detected by indirect in situ immunofluorescence with D71 as the primary
antiserum and tetramethyl rhodamine isothiocyanate-conjugated goat anti-rabbit
immunoglobulin G as the secondary antiserum. Immunoreactive cells were vi-
sualized at a magnification of 3790 by epifluorescence and recorded on Kodak
Tri-X film.
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The UL28 deletion proteins were then tested for the ability
to be directed to the nucleus during infection with the UL28-
null mutant PRV(332-31). This experiment tested the ability of
the UL28 deletion proteins to enter the nucleus in the pres-
ence of all other virus-induced proteins. Vero cells were trans-
fected and infected 24 h later with PRV(332-31) at a multi-
plicity of infection (MOI) of 10. The infection was terminated
6 h postinfection, and the cells were processed for examination
by immunofluorescence detection of UL28. Under these con-
ditions, the UL28, UL28D1, UL28D2, and UL28D3 proteins
were transported to the nucleus (Fig. 4A to D). The UL28D4
protein remained in the cytoplasm; its distribution was unaf-
fected by the infection. These data were consistent with the
specific transport of UL28 to the nucleus facilitated by one or
more other virus-induced proteins. Two additional observa-
tions were made: (i) there were no detectable UL28-positive
revertants contaminating the PRV(332-31) stock, as deter-
mined by a .6-log difference in plaque formation on Vero and
V108 cells as well as the inability to detect UL28 by immuno-
fluorescence in cells infected at an MOI of 10 with PRV(332-
31); and (ii) there was no detectable UL28 in the PRV(332-31)
virion preparation resulting from UL28 packaged in the virion,
as determined by the inability to detect UL28 in PRV(332-31)-
infected cells by immunofluorescence shortly after infection.
Therefore, the UL28 proteins detected were due to expression
from the transfected plasmids.
HSV-induced proteins provide nuclear transport for PRV
UL28. There is considerable conservation at the amino acid
level of several of the proteins involved in the packaging/
cleavage reaction among herpesviruses. The possibility that an
HSV-induced function could complement the PRV-induced
entry of transiently expressed UL28 into the nucleus was
tested. PRV UL28-transformed cells (V108 cells) were in-
fected with HSV(KOS) and examined by immunofluorescence
for the expression and distribution of PRV UL28 (Fig. 5A).
HSV infection induced the expression of PRV UL28 from the
V108 cell chromosome, and PRV UL28 was detected in both
the cytoplasm and the nucleus. The D71 antisera against PRV
UL28 did not cross-react with HSV UL28 as determined by
immunofluorescence or Western blot analyses (20). These re-
sults indicated that one or more HSV-induced proteins effec-
tively relocated UL28 to the nucleus. These results also sug-
gested that the virus-induced protein that transports UL28 to
the nucleus was conserved in HSV infection and that PRV
UL28 interacts with an HSV protein.
HSV UL15 directed PRV UL28 to the nucleus. The finding
that an HSV-induced function facilitated the transport of PRV
UL28 to the nucleus was explored. The sequence of the HSV
genome is known (12, 13), and the proteins required for pack-
aging are relatively well characterized compared to the PRV
proteins. Two HSV proteins required for packaging were
tested for their potential to direct UL28 to the nucleus. HSV
UL15 was chosen because (i) UL15 and UL28 are the two
most conserved proteins involved in encapsidation among her-
pesviruses and (ii) of the predicted masses of the known pack-
aging proteins, that of HSV UL15 was the closest to, and
FIG. 2. Structure of PRV UL28 protein variants. The UL28 proteins ex-
pressed in cells are diagrammed to scale. The names of the proteins, their
features, and the extent of their deletions are given.
FIG. 3. UL28 variant protein expression in Vero cells. Vero cells grown on coverslips were transfected and processed for immunofluorescent detection of PRV
UL28. (A) UL28; (B) UL28D1; (C) UL28D2; (D) UL28D3; (E) UL28D4. Magnification, 3580.
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slightly less than that of HSV UL28, reminiscent of the slightly
smaller protein which coimmunoprecipitated with PRV UL28
(19).
Plasmids encoding PRV UL28 and HSV UL15 were co-
transfected into Vero cells and examined by immunofluores-
cence 48 h later. Full-length PRV UL28 was redistributed to
the nucleus upon coexpression of HSV UL15 (Fig. 5B). The
effect of HSV UL15 on PRV UL28 localization was examined
further by testing the PRV UL28 deletion proteins. Each of the
plasmids encoding the PRV UL28 deletion proteins was co-
transfected with the plasmid encoding HSV UL15 (Fig. 5C to
F). Upon coexpression with HSV UL15, the UL28, UL28D1,
UL28D2, and UL28D3 proteins accumulated in the nucleus
whereas the UL28D4 protein did not. The proteins UL28,
FIG. 4. UL28 variant protein expression in PRV(332-31)-infected cells. Vero cells grown on coverslips were transfected with plasmids to express the indicated
proteins and infected with PRV(332-31) at an MOI of 10 24 h later. The cells were processed for immunofluorescent detection of PRV UL28 6 h postinfection. (A)
UL28; (B) UL28D1; (C) UL28D2; (D) UL28D3; (E) UL28D4. Magnification, 3580.
FIG. 5. UL28 variant proteins expressed in HSV-infected cells or coexpressed with HSV UL15. (A) V108 cells grown on coverslips were infected with HSV at an
MOI of 0.1 and processed for immunofluorescent detection of PRV UL28 6 h later. Alternatively, Vero cells grown on coverslips were transfected with plasmids to
express HSV UL15 plus UL28 (B), UL28D1 (C), UL28D2 (D), UL28D3 (E), or UL28D4 (F) and were processed for immunofluorescent detection of PRV UL28 48 h
later. Magnification, 3590.
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UL28D1, UL28D2, and UL28D3 appeared in the nucleus in
punctate patterns quite distinct from that seen in PRV(332-
31)-infected cells transfected with the deletion plasmids (Fig.
4). However, this experiment demonstrated that HSV UL15
was sufficient for directing PRV UL28 to the nucleus in a
process that required the carboxyl terminus of UL28.
HSV UL15 has been shown to enter the nuclei of infected
cells (4, 25). However, the distribution of HSV UL15 within
uninfected cells has not been described. Since the pattern of
PRV UL28 was altered by the expression of HSV UL15, the
subcellular distribution of UL15 was examined for possible
differences in localization due to PRV UL28. HSV UL15 was
examined by immunofluorescence in transfected Vero cells
(Fig. 6A) and was found within the nucleus, with distinct punc-
tate nuclear regions. When PRV UL28 was coexpressed with
HSV UL15 (Fig. 6B), no appreciable differences in the local-
ization of UL15 could be attributed to the expression of UL28.
The second protein examined for its ability to affect the
localization of PRV UL28 was HSV UL25. HSV UL25 did not
affect the distribution of full-length or deletion forms of PRV
UL28 in transfected cells (20). Although no change in the
distribution of UL28 could be attributed to HSV UL25, the
expression of HSV UL25 was examined to confirm that UL25
was expressed from the plasmid and to determine whether
UL25 was capable of entering the nucleus in the absence of
other viral proteins (Fig. 6C). UL25 was distributed through-
out the cell, and its distribution was not affected by the expres-
sion of UL28 (20). Therefore, although UL15, UL25, and
UL28 are involved in viral DNA encapsidation, only UL15
facilitated the transport of UL28 to the nucleus, the site of
encapsidation.
DISCUSSION
The phenotype of all UL28-null and UL28-temperature-
sensitive mutants is a cessation of viral replication at the point
of DNA cleavage and encapsidation (1, 6, 14, 17, 23). There-
fore, the presumed function of UL28 is to act in concert with
other proteins in the complex process of packaging viral DNA
into preformed capsids within the nuclei of infected cells. Con-
sistent with that finding, PRV UL28 was shown previously to
be in the nuclei of infected cells (19). Additionally, PRV UL28
was shown to be a component of an oligomer as detected by
immunoprecipitation of radiolabeled fractions from a sucrose
gradient (19). The experiments described above confirmed lo-
calization of UL28 to the nuclei of infected cells. Surprisingly,
in the absence of other viral proteins, UL28 was limited to the
cytoplasm. Further experiments revealed that the carboxyl-
terminal 155 amino acids of UL28 were required for nuclear
localization during PRV infection. These findings support the
model that UL28 forms an oligomer with another viral protein
for transport to the nucleus. These data also suggest that the
required domain lies within the carboxyl-terminal 155 amino
acids of UL28. This domain does not lie within the sequences
eliminated in UL28D1, UL28D2, or UL28D3, since those pro-
teins were able to be transported to the nucleus in the presence
of other viral proteins. This model does not explain the whole-
cell distribution of the UL28D2 protein in the absence of other
viral proteins.
At least two other possibilities remain. The required domain
may not lie in the C-terminal residues deleted in UL28D4 but in
the amino-terminal 92 amino acids. The folding of the truncated
UL28D4 protein may have affected access to, or the structure of,
the amino-terminal region so that the effect of HSV UL15 was
not realized. This model does not address the distribution of
UL28D2 either. Another model must be considered to explain the
distribution of UL28D2 in the nucleus and cytoplasm in the ab-
sence of other viral proteins. UL28 may possess an NLS that is
normally “masked” by a different domain. The masking effect
may be reversed by the binding of another viral protein, such as
UL15. If the NLS exists in the region deleted in UL28D4 and the
masking domain exists in the region deleted in UL28D2, then
UL28D2 would be expected to enter the nucleus in the absence of
other viral proteins. Consistent with the data, each of the UL28
deletion proteins except for UL28D4 would be expected to be
able to enter the nucleus in the presence of UL15. Although this
FIG. 6. Expression of HSV UL15 and HSV UL25. Vero cells grown on
coverslips were transfected with plasmids to express HSV UL15 (A), HSV UL15
plus PRV UL28 (B), or HSV UL25 (C). The cells were processed for immuno-
fluorescent detection of HSV UL15 (A and B) or HSV UL25 (C). Magnification,
3790.
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model accounts for UL28 distribution patterns in the absence of
other viral proteins, it is inconsistent with the data for the distri-
bution patterns when UL15 was coexpressed. If the effect of
UL15 or another protein was to bind to the region deleted in
UL28D2, then UL28D2 would not be expected to be affected in
the presence of UL15 or other infected-cell proteins. A significant
difference was seen, however (Fig. 3C, 4C, and 5D). Further work
is needed to exclude one or more of these models.
The identification of a domain within UL28 that is required
for UL28 to reach the nucleus is significant because the region
acts unlike a typical NLS. HSV UL15 was found to be sufficient
to enable PRV UL28 to enter the nucleus. Other viral proteins
may also be capable of directing UL28 to the nucleus, but the
inability of UL25 to direct UL28 to the nucleus suggests that
the interaction is specific. It remains to be confirmed that PRV
UL15 affects PRV UL28 in a similar manner. Currently, only
the DNA sequence of the second exon of PRV UL15 has been
reported (10). The sequences of the PRV UL15 splice junction
and first exon remain to be determined. Similarly, the effect of
HSV UL15 coexpression on PRV UL28 localization suggests,
but does not confirm, that HSV UL15 affects HSV UL28
localization.
The degree of similarity of the required domains of the PRV
UL28 and HSV UL15 proteins may contrast with that of other
domains required for encapsidation of the respective virus
genomes. The HSV(gCB) UL28-null mutant did not form
plaques on the PRV UL28-complementing cell line V108,
which suggests that there is at least one other virus-specific
domain of UL28 (20). The possibility of additional indepen-
dently functioning domains within UL28 is supported by the
complementation of different temperature-sensitive HSV
UL28 mutants (6).
The finding that HSV UL15 was capable of entering the
nucleus in the absence of other proteins further substantiates
the observation that UL15 enters the nucleus during infection
with HSV (4, 25). The significance of the punctate pattern of
UL15 (Fig. 6A) in the absence of other viral proteins is not
known. The significance of the punctate pattern of UL28 in the
presence of UL15 is not known, but the pattern has also been
seen at early times in PRV infection (19). Another consider-
ation is whether the effect on UL28 is due to UL15 or UL15.5
(3, 27) or both, since both proteins are presumably expressed
in transfected cells but cannot be distinguished in immunoflu-
orescence analyses by existing antisera.
An effect of one protein involved in the packaging/cleavage
reaction on another has been identified in living cells. This
represents the first demonstrated potential interaction be-
tween any of the proteins required for viral DNA encapsida-
tion among herpesviruses. The significance is strengthened by
the finding that the specificity of the interaction is maintained
between different alphaherpesviruses.
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